Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVoyager Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 6 | -$0.84 | -$0.20 | -$0.43 |
| Q2 2025 | 5 | -$0.85 | $0.08 | -$0.35 |
| Q3 2025 | 5 | -$0.85 | $0.08 | -$0.36 |
| Q4 2025 | 5 | -$1.05 | $0.09 | -$0.44 |
| Q1 2026 | 2 | -$1.19 | $0.11 | -$0.50 |
| Q2 2026 | 2 | -$1.20 | $0.11 | -$0.50 |
| Q3 2026 | 2 | -$1.27 | $0.11 | -$0.53 |
| Q4 2026 | 2 | -$1.22 | $0.11 | -$0.51 |
Voyager Therapeutics, Inc. Earnings Date And Information
Voyager Therapeutics, Inc. last posted its earnings results on Tuesday, March 11th, 2025. The company reported $-0.59 earnings per share for the quarter, missing analysts' consensus estimates of $-0.35 by $0.24. The company had revenue of 6.28 M for the quarter and had revenue of 80.00 M for the year. Voyager Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.13 diluted earnings per share) and currently has a price-to-earnings ratio of -3.6. Voyager Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Voyager Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/11/2025 | Q4 2024 | -$0.35 | $0.00 | N/A | N/A | $6.28 M |
| 11/12/2024 | Q3 2024 | -$0.45 | -$0.16 | 0.29 | $11.70 M | $24.63 M |
| 08/06/2024 | Q2 2024 | -$0.38 | -$0.18 | 0.2 | $9.51 M | $29.58 M |
| 05/13/2024 | Q1 2024 | -$0.44 | -$0.20 | 0.24 | N/A | $19.52 M |
| 12/30/2023 | Q4 2023 | N/A | $1.28 | N/A | N/A | $90.06 M |
| 11/06/2023 | Q3 2023 | -$0.58 | -$0.59 | -0.01 | $2.91 M | $4.61 M |
| 08/03/2023 | Q2 2023 | -$0.59 | -$0.51 | 0.08 | $1.60 M | $4.85 M |
| 05/09/2023 | Q1 2023 | $0.77 | $3.05 | 2.28 | N/A | $150.48 M |
| 03/07/2023 | Q4 2022 | -$0.57 | -$0.61 | -0.04 | N/A | $-41,087,000 |
| 11/08/2022 | Q3 2022 | -$0.32 | $0.46 | 0.78 | $9.42 M | $41.09 M |
| 08/04/2022 | Q2 2022 | -$0.56 | -$0.49 | 0.07 | $7.03 M | $712,000 |
| 05/04/2022 | Q1 2022 | -$0.14 | -$0.56 | -0.42 | N/A | $658,000 |
| 03/08/2022 | Q4 2021 | -$0.32 | $0.15 | 0.47 | N/A | $28.07 M |
| 11/02/2021 | Q3 2021 | -$0.75 | -$0.67 | 0.08 | $2.14 M | $1.48 M |
| 08/09/2021 | Q2 2021 | -$0.75 | -$0.80 | -0.05 | $4.18 M | $1.36 M |
| 05/10/2021 | Q1 2021 | -$0.71 | -$0.58 | 0.13 | N/A | $6.50 M |
| 02/25/2021 | Q4 2020 | -$0.52 | -$0.43 | 0.09 | N/A | $6.54 M |
| 11/09/2020 | Q3 2020 | -$0.19 | $2.30 | 2.49 | $15.05 M | $117.84 M |
| 08/10/2020 | Q2 2020 | -$0.75 | -$0.23 | 0.52 | $16.52 M | $28.68 M |
| 05/06/2020 | Q1 2020 | -$0.87 | -$0.66 | 0.21 | N/A | $18.07 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Voyager Therapeutics, Inc. Earnings: FAQ's
Voyager Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based offlast year's report dates.
The conference call for Voyager Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Voyager Therapeutics, Inc.'s latest earnings report can be read online.
Voyager Therapeutics, Inc. (:VYGR) has a recorded annual revenue of $80.00 M.
Voyager Therapeutics, Inc. (:VYGR) has a recorded net income of $-65,002,000.Voyager Therapeutics, Inc. has generated $-1.13 earnings per share over the last four quarters.
Voyager Therapeutics, Inc. (:VYGR) has a price-to-earnings ratio of -3.6 and price/earnings-to-growth ratio is 0.02.